200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 131060-14-5

131060-14-5

131060-14-5 | Benzenemethanamine, 3-([3,3'-bithiophen]-5-ylmethoxy)-N-[(2E)-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-ethyl-

CAS No: 131060-14-5 Catalog No: AG000VGJ MDL No:MFCD00898838

Product Description

Catalog Number:
AG000VGJ
Chemical Name:
Benzenemethanamine, 3-([3,3'-bithiophen]-5-ylmethoxy)-N-[(2E)-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-ethyl-
CAS Number:
131060-14-5
Molecular Formula:
C27H31NOS2
Molecular Weight:
449.6711
MDL Number:
MFCD00898838
IUPAC Name:
(E)-N-ethyl-6,6-dimethyl-N-[[3-[(4-thiophen-3-ylthiophen-2-yl)methoxy]phenyl]methyl]hept-2-en-4-yn-1-amine
InChI:
InChI=1S/C27H31NOS2/c1-5-28(14-8-6-7-13-27(2,3)4)18-22-10-9-11-25(16-22)29-19-26-17-24(21-31-26)23-12-15-30-20-23/h6,8-12,15-17,20-21H,5,14,18-19H2,1-4H3/b8-6+
InChI Key:
KIRGLCXNEVICOG-SOFGYWHQSA-N
SMILES:
CCN(Cc1cccc(c1)OCc1scc(c1)c1cscc1)C/C=C/C#CC(C)(C)C

Properties

Complexity:
628  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
449.185g/mol
Formal Charge:
0
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
449.671g/mol
Monoisotopic Mass:
449.185g/mol
Rotatable Bond Count:
10  
Topological Polar Surface Area:
69A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
7.2  

Literature

Title Journal
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. Journal of cellular physiology 20110901
Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. Endocrinology 20081001
Synthesis and biological activity of a novel squalene epoxidase inhibitor, FR194738. Bioorganic & medicinal chemistry letters 20040209
Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes. Journal of lipid research 20030101
[Other antihyperlipidemic drugs with novel mechanism]. Nihon rinsho. Japanese journal of clinical medicine 20010301
Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells: a new type of potent squalene epoxidase inhibitors. Bioorganic & medicinal chemistry letters 19980602
(Aryloxy)methylsilane derivatives as new cholesterol biosynthesis inhibitors: synthesis and hypocholesterolemic activity of a new class of squalene epoxidase inhibitors. Journal of medicinal chemistry 19950818

Related Products

© 2019 Angene International Limited. All rights Reserved.